Gain Therapeutics, Inc.
For the period ended Jun 24, 2024. Filed Apr 26, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 24, 2024 · Filed Apr 26, 2024
Use the contents to explore the available documents and sections.
GANX$1.03+7.2%Stored close · as of Nov 6, 2026
Contents
Cover page
Show cover page
DEF 14A 1 tmb-20240624xdef14a.htm DEF 14A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934
(Amendment No.__)
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.